Bridgebio Pharma, Inc. · NASDAQ:BBIO
Scott Randal W. sold 10,000 Bridgebio Pharma, Inc. shares (Form 4)
Traded May 15, 2026 · Filed May 19, 2026
On May 15, 2026, Scott Randal W. (Director) sold 10,000 Bridgebio Pharma, Inc. shares at an average US$67.15 for US$671K under a trading plan, leaving 11,589 shares. Filed May 19, 2026 (Form 4).
- Sold
- 10,000 shares
- Price
- US$67.15 average (US$66.69 to US$69.12)
- Value
- US$671K
- Holding after
- 11,589 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 15, 2026 | Common Stock | Option exercise | 10,000 | US$16.75 | 21,589 | Direct |
| May 15, 2026 | Common Stock | Sale | 6,200 | US$66.69 | 15,389 | Direct |
| May 15, 2026 | Common Stock | Sale | 2,088 | US$67.53 | 13,301 | Direct |
| May 15, 2026 | Common Stock | Sale | 1,512 | US$68.23 | 11,789 | Direct |
| May 15, 2026 | Common Stock | Sale | 200 | US$69.12 | 11,589 | Direct |